Torrent Pharma Enters Into Voluntary Licensing Agreement With Eli Lilly For Baricitinib For Covid-19

Torrent Pharma Enters Into Voluntary Licensing Agreement With Eli Lilly For Baricitinib For Covid-19

By, Admin 17 May 2021

Torrent Pharmaceuticals Limited Announced That It Has Entered Into A Royalty Free, Non-Exclusive Voluntary Licensing Agreement With Eli Lilly And Company, Joining A Group Of Leading Indian Pharmaceutical Companies For Baricitinib For Covid-19 In India.Under The Agreement, Lilly Has Provided The License To Manufacture And Distribute Baricitinib To Torrent For India Along With Lilly&Rsquo;S Other License Partners.The Agreement Will Help Ensure Wider Reach And Access To Patients In India And Further Adds To Torrent Pharma&Rsquo;S Effort In Helping Patients Affected By The Pandemic. Baricitinib Has Been Approved By The Central Drug Standard Control Organisation (Cdsco), India For Restricted Emergency Use In Combination With Remdesivir For The Treatment Of Suspected Or Laboratory Confirmed Covid-19 In Hospitalized Adults Requiring Supplemental Oxygen, Invasive Mechanical Ventilation Or Extracorporeal Membrane Oxygenation.Commenting On The Agreement, Aman Mehta, Chief Marketing Officer For Torrent Said, &Ldquo;We Are Pleased To Partner And Work Closely With Lilly To Bring This Treatment To Market. This Partnership Further Strengthens Our Efforts To Help The Nation Fight The Pandemic And Provide Quality Treatment To Patients. Torrent Group Stands Firmly Committed To Support The Nation During This Time Of Crisis.&Rdquo;

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!